Related Experiment Videos
The emergency management of hyperglycemic-hyperosmolar nonketotic coma in the pediatric patient
M E Gottschalk1, S P Ros, W P Zeller
1Department of Pediatrics, Loyola University Medical Center, Maywood, IL 60153, USA.
Insights
In comatose pediatric patients, treat hyperosmolar hyperglycemic non-ketotic coma (HHNK) with prompt fluid therapy. Avoid insulin initially, as it may cause dangerous cerebral edema in children.
Area of Science:
- Pediatric Endocrinology
- Critical Care Medicine
- Neurology
Background:
- Hyperosmolar hyperglycemic non-ketotic coma (HHNK) is a serious complication of diabetes.
- Pediatric HHNK presents unique management challenges compared to adults.
Observation:
- Comatose pediatric patients require careful consideration for HHNK.
- Cerebral edema is a significant risk during HHNK treatment in children.
Findings:
- Initial management focuses on fluid resuscitation and electrolyte correction.
- Gradual normalization of serum tonicity is crucial for preventing complications.
- Insulin therapy is not indicated in the initial treatment phase and may be harmful.
Implications:
- Prompt fluid therapy is key for managing pediatric HHNK.
- Avoiding early insulin can prevent potentially fatal cerebral complications.
- This approach optimizes outcomes for critically ill children with HHNK.
Abstract:
We recommend consideration of HHNK in comatose pediatric patients and advocate the prompt institution of fluid therapy. Insulin is not required during the initial course of treatment and potentially can have adverse effects. Compared to adults, pediatric patients appear to be at a greater risk of developing potentially fatal cerebral during the course of treatment. In order to prevent complications associated with the rapid decrease in serum tonicity the initial management should consist of fluid therapy directed toward repleting the intravascular volume, correcting electrolyte abnormalities, and slowly returning serum tonicity to normal.